Product Information
ACETAMINOPHEN 325 MG TABLET is a generic product labeled by Rugby Laboratories, priced at $0.0250 per EA under NDC 00536132701. Its NADAC has been published 267 times since May 19, 2021.
Strength
325 mg/1
Manufacturer
Rugby LaboratoriesNDC
00536132701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
3/11/2021
Price Statistics
The NADAC for ACETAMINOPHEN 325 MG TABLET has been published 267 times since May 19, 2021, and over the history we have for it it has risen 39.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0250 per EA |
|---|---|
| All-time high | $0.0267 (Nov 13, 2024) |
| All-time low | $0.0180 (May 19, 2021) |
| 52-week high | $0.0267 |
| 52-week low | $0.0247 |
| Median price | $0.0243 |
| Average price | $0.0241 |
| Largest weekly change | +33.8% (Jun 23, 2021) |
| Weeks tracked | 267 |
| Tracking since | May 19, 2021 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 325 MG TABLET, manufactured by Rugby Laboratories, is $0.0250 per EA (NDC 00536132701), effective Jun 24, 2026.
How has the price of ACETAMINOPHEN 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 325 MG TABLET has risen 39.1%. It has been tracked across 267 weekly CMS publications since May 19, 2021.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 325 MG TABLET?
Since May 19, 2021, the NADAC for ACETAMINOPHEN 325 MG TABLET has ranged from a low of $0.0180 (May 19, 2021) to a high of $0.0267 (Nov 13, 2024), with a median of $0.0243 per EA.
Are there cheaper alternatives to ACETAMINOPHEN 325 MG TABLET?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC PAIN RELIEF 325 MG TABLET, is $0.0232 per EA — about 7% below ACETAMINOPHEN 325 MG TABLET.
Who manufactures ACETAMINOPHEN 325 MG TABLET?
ACETAMINOPHEN 325 MG TABLET (NDC 00536132701) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification